1. Home
  2. PACB vs HCAT Comparison

PACB vs HCAT Comparison

Compare PACB & HCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • HCAT
  • Stock Information
  • Founded
  • PACB 2000
  • HCAT 2008
  • Country
  • PACB United States
  • HCAT United States
  • Employees
  • PACB N/A
  • HCAT N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • HCAT Computer Software: Programming Data Processing
  • Sector
  • PACB Industrials
  • HCAT Technology
  • Exchange
  • PACB Nasdaq
  • HCAT Nasdaq
  • Market Cap
  • PACB 452.1M
  • HCAT 464.4M
  • IPO Year
  • PACB 2010
  • HCAT 2019
  • Fundamental
  • Price
  • PACB $2.42
  • HCAT $8.86
  • Analyst Decision
  • PACB Buy
  • HCAT Buy
  • Analyst Count
  • PACB 15
  • HCAT 10
  • Target Price
  • PACB $3.79
  • HCAT $11.56
  • AVG Volume (30 Days)
  • PACB 9.3M
  • HCAT 486.0K
  • Earning Date
  • PACB 11-07-2024
  • HCAT 11-06-2024
  • Dividend Yield
  • PACB N/A
  • HCAT N/A
  • EPS Growth
  • PACB N/A
  • HCAT N/A
  • EPS
  • PACB N/A
  • HCAT N/A
  • Revenue
  • PACB $188,871,000.00
  • HCAT $302,062,000.00
  • Revenue This Year
  • PACB N/A
  • HCAT $5.98
  • Revenue Next Year
  • PACB $27.48
  • HCAT $11.42
  • P/E Ratio
  • PACB N/A
  • HCAT N/A
  • Revenue Growth
  • PACB 29.24
  • HCAT 4.15
  • 52 Week Low
  • PACB $1.16
  • HCAT $5.42
  • 52 Week High
  • PACB $10.65
  • HCAT $11.41
  • Technical
  • Relative Strength Index (RSI)
  • PACB 73.20
  • HCAT 64.84
  • Support Level
  • PACB $2.38
  • HCAT $7.41
  • Resistance Level
  • PACB $2.40
  • HCAT $8.05
  • Average True Range (ATR)
  • PACB 0.20
  • HCAT 0.48
  • MACD
  • PACB 0.07
  • HCAT 0.03
  • Stochastic Oscillator
  • PACB 89.31
  • HCAT 88.96

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Share on Social Networks: